Sign inJoin waitlistJoin the waitlist

Patrick Hensley

Assistant Professor · University of Kentucky College of Medicine

Credentials: · · · ·

History

University of Kentucky College of Medicine
Present
North Fork Valley Community Health Center
Present

University of Texas M D Anderson Cancer Center
2022–2023
Pathology
University of Kentucky College of Medicine
2021–2022
Urology
University of Kentucky College of Medicine
2016–2021
University of Kentucky College of Medicine
2011–2015
Miami University in Oxford, OH
2007–2011

Research

Targeting caspases in cancer therapeutics
Review · Biological Chemistry · 2013 · First of 3 authors · 120 citations
Updated European Association of Urology (EAU) Prognostic Factor Risk Groups Overestimate the Risk of Progression in Patients with Non-muscle-invasive Bladder Cancer Treated with…
European Urology Oncology · 2022 · 67 citations
PARP-1 regulates epithelial-mesenchymal transition (EMT) in prostate tumorigenesis
Carcinogenesis · 2014 · 61 citations

Ashish Kamat
48 papers
Kelly Bree
29 papers · 21 as a fellow
Neema Navai
26 papers
Colin Dinney
24 papers
RL
Roger Li
22 papers
Charles Guo
13 papers
Derek Allison
13 papers
Surena Matin
11 papers
NB
Nathan Brooks
10 papers · 5 as a fellow
PS
Philippe Spiess
10 papers
Stephen Strup
10 papers
Amanda Buchanan
9 papers · 6 as a fellow

Clinical trials

Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer
Principal investigator · Completed · Phase 2
Patrick Hensley
2019–2024
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Site PI · Recruiting · Phase 2, Phase 3
National Cancer Institute (NCI)
2024–2030
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Site PI · Recruiting · Phase 2, Phase 3
National Cancer Institute (NCI)
2021–2027
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2018–2031